ArticleCureus2021

Pretreatment Neutrophil-to-Lymphocyte Ratio: A Prognostic Biomarker of Survival in Patients With Epithelial Ovarian Cancer.

Sarah O John-Olabode et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.